Novel withanolides target medullary thyroid cancer through inhibition of both RET phosphorylation and the mammalian target of rapamycin pathway

BACKGROUND: Despite development of current targeted therapies for medullary thyroid cancer (MTC), long-term survival remains unchanged. Recently isolated novel withanolide compounds from Solanaceae physalis are highly potent against MTCs. We hypothesize that these withanolides uniquely inhibit RET p...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Samadi, Abbas K., Bazzill, Joseph, Zhang, Xuan, Gallagher, Rob, Zhang, Hauping, Gollapudi, Rao, Kindscher, Kelly, Timmermann, Barbara, Cohen, Mark S.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2012
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3992287/
https://ncbi.nlm.nih.gov/pubmed/23158190
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.surg.2012.08.031
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items